文献速递临床试验与 GCP医学人工智能与信息学

0Phobia:虚拟现实暴露疗法治疗恐高症随机对照试验方案

0Phobia - towards a virtual cure for acrophobia: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-08-09

本研究为一项随机对照试验方案,计划从荷兰普通人群招募180名18-65岁恐高症症状参与者,随机分为0Phobia组(n=90)和等待名单对照组(n=90)。0Phobia是一种通过智能手机应用结合简易纸板VR眼镜提供的游戏化自我引导虚拟现实暴露疗法,为期3周,包含心理教育、VR暴露、认知技术、症状监测和复发预防。主要结局为恐高症问卷,评估在基线、干预后即刻和3个月随访时在线进行。

要点

  • 0Phobia是游戏化自我引导VRET,通过手机应用和简易VR眼镜交付,为期3周。
  • 研究计划招募180名恐高症症状成人,随机分为干预组和等待名单对照组各90人。
  • 主要结局为恐高症问卷,评估在基线、干预后即刻和3个月随访时在线进行。

核心结论

  • 该研究方案旨在评估0Phobia游戏化自我引导VRET对恐高症症状的疗效。

研究设计与样本

  • 随机对照试验方案,计划从荷兰普通人群招募180名18-65岁恐高症症状参与者,随机分为0Phobia组(n=90)和等待名单对照组(n=90)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Virtual reality exposure therapy (VRET) has been shown to be as effective as traditional forms of in vivo exposure therapy for the treatment of specific phobias. However, as with in vivo exposure, VRET still involves relatively high costs and limited accessibility which makes it prohibitive for a large part of the population. Innovative methods using smartphone applications (apps) may improve accessibility and scalability of VRET. The aim of this study is to evaluate 0Phobia, a gamified self-guided VRET for acrophobia that is delivered through a smartphone app in combination with rudimentary cardboard virtual reality (VR) goggles. METHODS/DESIGN: Participants (N = 180, aged 18-65 years) with acrophobia symptoms will be recruited from the Dutch general population and randomized to either 0Phobia (n = 90) or a waitlist control condition (n = 90). 0Phobia will be delivered over a period of 3 weeks and includes psychoeducation, VR exposure, cognitive techniques, monitoring of symptoms, and relapse prevention. The primary outcome measure will be the Acrophobia Questionnaire. Secondary outcome measures will include user-friendliness, symptoms of anxiety, depression, and mastery. Assessments will take place online at baseline, directly after the intervention (post test) and at follow-up (3 months). DISCUSSION: This study capitalizes on novel technology and recent scientific advances to develop an affordable and scalable treatment modality. TRIAL REGISTRATION: Netherlands Trial Register: NTR6442 . Registered on 29 June 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Donker T, Van Esveld S, Fischer N, et al. 0Phobia - towards a virtual cure for acrophobia: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30092844. doi:10.1186/s13063-018-2704-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。